Vilhelm Bohr is an Affiliate Professor at the Department of Cellular and Molecular Medicine , University of Copenhagen, affiliated with the Molecular Aging Program and Center for Healthy Aging . His research explores the interplay between DNA maintenance , mitochondrial biology , and aging , particularly in age-associated neurodegeneration and Alzheimer’s disease. Research Interests include: Molecular mechanisms linking NAD + metabolism to mitochondrial dysfunction and neurodegeneration Role of tau pathology in DNA damage and mitochondrial stress Impact of Aprataxin (APTX) and RECQL4 helicase defects on mitochondrial DNA integrity Pharmacological strategies to improve mitochondrial health via autophagy modulation Publications (2025-2024) span topics like NAD + biosynthesis, Werner/Rothmund-Thomson syndromes, tau nuclear functions, and mitochondrial turnover, with high citations and media attention. Collaborations extend to clinical tumor samples and CRISPR-based disease models.
Jens S. Andersen is a Professor in the Department of Biochemistry and Molecular Biology at the University of Southern Denmark, where he leads research in Biomedical Mass Spectrometry and Systems Biology. His work is centered on the development and application of quantitative mass spectrometry and microscopy-based proteomics to study human cell biology, particularly the structure and function of organelles such as centrosomes, cilia, autophagosomes, and mitochondria. His research focuses on determining the protein composition and dynamic properties of cellular organelles, the roles of specific protein groups, and their contributions to biological processes and diseases. He investigates cell signaling mediated by post-translational modifications, especially within the DNA damage response, autophagy, and immune systems. His lab, the Jens S. Andersen Lab, is part of the Research Section of Biomedical Mass Spectrometry. The analysis of his recent publications reveals a strong interdisciplinary trend combining proteomics, structural biology, and cell signaling. His work spans cilia biology, RNA metabolism, DNA repair, and cancer mechanisms, with frequent use of advanced techniques like mass spectrometry, CRISPR, and live-cell imaging. The integration of systems biology approaches is evident across his research outputs. Professor, Department of Biochemistry and Molecular Biology, University of Southern Denmark Head of Research, Biomedical Mass Spectrometry and Systems Biology Principal Investigator, Jens S. Andersen Lab ORCID: 0000-0002-6091-140X While no specific scientific awards are mentioned in the provided texts, his extensive publication record in high-impact journals such as Science , Nature Communications , Molecular Cell , and EMBO Journal reflects significant scholarly contributions. He has supervised research projects and collaborated widely across Europe, though specific names of students are not listed. His research is supported by multiple ongoing projects, reflecting sustained funding and academic leadership. The Jens S. Andersen Lab operates at the intersection of proteomics and cell biology, contributing to fundamental understanding of organelle dynamics and disease mechanisms. The lab's work is highly collaborative, involving partnerships with groups in structural biology, RNA research, and cancer biology.
Maria Timofeeva is an Associate Professor in the Epidemiology, Biostatistics and Biodemography (EBB) department at the University of Southern Denmark (SDU), with additional affiliation at the Danish Institute for Advanced Study (DIAS). She holds an Honorary Fellow position at the University of Edinburgh since December 2019. Her research focuses on cancer prevention and prediction, particularly studying the effects of environmental and genetic factors on cancer risk and progression. Dr. Timofeeva earned her Dr.sc.hum in Epidemiology from Heidelberg University (2005-2009), with a dissertation on genetic polymorphisms as risk factors for early onset lung cancer. Prior to her current position, she worked as a Statistical Geneticist at the University of Edinburgh (2013-2019) and as a Postdoctoral Fellow at the International Agency for Research on Cancer (2009-2013). Her research interests center around understanding the genetics of cancer risk through multi-omic analysis. She leads several significant projects, including the Interdisciplinary Project on Adherence to Colorectal Cancer Screening, meta-analysis of factors associated with false-positive and false-negative FOBT results (registered in PROSPERO ID: CRD42022315767), and the COlorectal Cancer screening Among RElatives (CoCARE) twin-family study in Denmark. Her methodological expertise spans observational epidemiological studies (case-control, population-based cohort studies, twin studies), meta-analysis, umbrella reviews, and multi-omics data analysis. Analysis of her recent publications reveals a strong focus on colorectal cancer genetics, with particular emphasis on genome-wide association studies, Mendelian randomization approaches, and trans-ancestry analyses. Her work frequently leverages large datasets including the UK Biobank and international consortia, with applications in cancer risk prediction and understanding gene-environment interactions. Dr. Timofeeva has an extensive publication record with 73 publications listed in her profile. Her research has been cited across multiple platforms, with mentions in news outlets, social media, and academic readership platforms like Mendeley. She is actively involved in academic service, serving as a peer reviewer for journals including BMC Cancer and Scientific Reports, and participating in conferences such as the 26th Nordic Congress of Gerontology. She also serves on evaluation committees, including with the World Cancer Research Fund International (April-May 2024). Her teaching activities include courses on evidence-based drug utilization and biostatistics, as well as supervision of research projects on gene expression in twins. Dr. Timofeeva has engaged with the public through media contributions, including an interview titled 'Jeg vil forstå, hvorfor vi får kræft' (November 15, 2021), where she discussed understanding why we get cancer.
Kumar Somyajit is Associate Professor at the University of Southern Denmark's Department of Biochemistry and Molecular Biology. He leads research on DNA replication and genome surveillance mechanisms using mammalian cell models. Research focuses on: Metabolic regulation of DNA replication Replisome plasticity under stress Homology-directed repair mechanisms Chromatin dynamics in cancer Recipient of Lundbeck Foundation Fellowship (2021). Current projects investigate metabolic coupling to genome surveillance in cancer and development. Supervises PhD students in DNA repair and replication studies.
Professor Guillermo Montoya is a Research Director and Group Leader at the Protein Structure & Function Program of the Novo Nordisk Foundation Center for Protein Research (CPR), University of Copenhagen, Denmark. His work focuses on unraveling cellular mechanisms at the atomic level through advanced methodologies including X-ray crystallography and cryo-electron microscopy. PhD in Chemistry, University of Zaragoza (1989–1993) MSc in Biochemistry, University of the Basque Country (1984–1989) Montoya's research spans Structural Molecular Biology and Genome Integrity , with specific emphasis on: Activation mechanisms of oligomeric kinases CRISPR-Cas12a conformational dynamics Macromolecular complexes in telomere maintenance His publications reveal significant contributions to CRISPR-Cas systems , kinase activation , and DNA/RNA degradation mechanisms . Scientific Awards: EMBO Member (2018) Spanish National Prize in Biomedicine (2009) Multiple Fellowships (EMBO, Marie Curie, FEBS, Marie Curie) Montoya's group integrates structural biology with cell biology to address fundamental questions in genome stability and biomedical applications. His work has been cited over 188 times for studies on CRISPR-Cas endonucleases and has attracted attention from 41 patents.
Ole Nørregaard Jensen is a Professor in Biomedical Mass Spectrometry and Systems Biology at the Department of Biochemistry and Molecular Biology, University of Southern Denmark . His research integrates advanced mass spectrometry, proteomics, and bioinformatics to study chromatin biology, post-translational modifications, and cellular signaling networks. He is actively involved in major research initiatives funded by Novo Nordisk Foundation and Lundbeck Foundation. His research interests include Mass Spectrometry, Proteomics, Posttranslational Modification, Histone Biology, Chromatin Biology, Bioinformatics, Systems Biology, Lipidomics, and Protein Chemistry . He employs cutting-edge techniques such as tandem mass spectrometry and ion mobility spectrometry to analyze protein isomers and dynamic modifications. His work has significant implications for understanding gene regulation, DNA replication, and disease mechanisms. His recent publications demonstrate a strong trend in chromatin dynamics, epigenetics, and integrated omics approaches , combining proteomics with transcriptomics and lipidomics to unravel complex biological systems. His research spans from fundamental molecular mechanisms to translational applications in biomedicine and food science. He has been recognized with several prestigious awards: MCP Lectureship Award Juan Pablo Albar Proteomics Pioneer Award 2019 EliteForsk 2009 prize Knight Order of Dannebrog (Ridder af Dannebrogordenen) Jensen is deeply involved in academic service, including peer review for journals like Nature Communications and Molecular and Cellular Proteomics , organizing conferences, and supervising students. He teaches courses such as Biomedical Mass Spectrometry - Principles and Applications and coordinates the Computational Biomedicine international Master’s program. He leads multiple active research projects, including PLATO and INTEGRA, focusing on health data, imaging, and protein networks. He is a key member of a vibrant research environment in biomedical mass spectrometry at SDU, contributing to both national and international scientific collaborations. His lab is at the forefront of developing and applying novel mass spectrometry methodologies for systems biology.
Sharath Anugula serves as a Guest Researcher in the Department of Cellular and Molecular Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, specifically within the Molecular Aging Program and Juel-Rasmussen Group. His research is centered at Panum Instituttet in Copenhagen. Dr. Anugula's research interests focus on the intricate relationship between mitochondrial function, genomic stability, and aging processes. His work bridges molecular biology, genetics, and systems approaches to understand fundamental mechanisms of biological aging. He has made significant contributions to understanding how DNA repair mechanisms, particularly REV1-mediated processes, interact with mitochondrial metabolism in aging contexts. His publication record demonstrates expertise in mitochondrial biology, with research examining how metabolic shifts, genomic instability, and nucleotide synthesis pathways influence aging trajectories and disease development. His work often employs both experimental and computational approaches to model complex biological systems. Anugula completed his Ph.D. at the University of Copenhagen in 2021 with research focused on nucleus-mitochondria communication in healthy aging. His scholarly output includes journal articles in Heliyon, Mitochondrion, and Experimental Gerontology, as well as book chapters on aging biology. His collaborative research network includes prominent scientists in aging research, particularly Professor Lene Juel Rasmussen, with whom he has published multiple studies examining the molecular underpinnings of aging processes.
Thomas Miller is an Associate Professor in the Department of Cellular and Molecular Medicine at the University of Copenhagen, working within the Molecular Aging Program. His research focuses on understanding the molecular mechanisms that maintain eukaryotic genome stability during DNA replication using genetic, biochemical, cellular, and structural techniques, including cryo-EM. Dr. Miller's primary research interests include: Molecular mechanisms of faithful genome replication How failures in genome stability maintenance cause developmental disorders and age-related diseases The role of replisomes and accessory factors in regulating chromosome replication His current research projects specifically investigate: The mechanisms and regulation of MCM helicase loading Replication-coupled DNA-protein crosslink (DPC) repair Accessory helicases in DNA replication Electron microscopy methods development through 'Reconstitution in silico' (RECONSIL) Dr. Miller's publication record demonstrates expertise across structural biology, molecular mechanisms of DNA replication, and cryo-EM techniques. His recent work spans from fundamental studies of replisome structure and function to developing new methodologies for studying DNA replication processes. His research has significant implications for understanding developmental disorders and age-related diseases including neurodegeneration and cancer. Dr. Miller is the founder of TCRM Consulting, indicating industry engagement alongside his academic work.
Professor Ian David Hickson is a distinguished academic serving as Professor of Molecular Aging, Head of the Department of Cellular and Molecular Medicine, and Theme Leader in the Center for Healthy Aging at the University of Copenhagen's Faculty of Health Sciences. He also directs the DNRF Center for Chromosome Stability, a major research center funded by a 65,000,000 DKK grant from the Danish National Research Foundation. Hickson's research focuses on understanding chromosomal instability and its impact on human disease, particularly cancer, neurodegeneration, and infertility. His laboratory pioneered the discovery of ultra-fine anaphase bridges (UFBs) and identified MiDAS (Mitotic DNA Synthesis), a process that completes DNA replication at difficult-to-replicate regions. His work combines protein biochemistry, molecular/cell biology, high-resolution imaging, and single-molecule biophysical techniques to study DNA metabolism and chromosome dynamics. The most recent publications demonstrate continued leadership in chromosome biology, with research spanning DNA topology, replication stress, chromosome mechanics, and the connection between DNA repair defects and cancer immunotherapy resistance. His work shows consistent focus on fundamental mechanisms of genome maintenance with clear implications for human disease. Fellow of the Royal Society (2010) Fellow of the Academy of Medical Sciences (UK) (2010) Member of EMBO (2011) ERC Advanced Grant recipient (2012) FEBS National Lecturer Award (2013) Professor Hickson has supervised over 40 PhD students who have gone on to prominent positions worldwide, including professors at major universities, group leaders at research institutes, and scientific officers in biotech companies. His laboratory has established international collaborations across Europe, the US, and Asia, particularly with Zhejiang University in China where he holds a Qiushi Guest Professorship. He actively participates in organizing major international conferences on DNA replication and chromosome stability.
Thomas J.D. Jørgensen is an Associate Professor at the Department of Biochemistry and Molecular Biology, University of Southern Denmark. His work focuses on Biomedical Mass Spectrometry and Systems Biology, with a particular emphasis on protein dynamics, lipoprotein metabolism, and structural characterization. Current research involves lipoprotein lipase regulation (ANGPTL3/8, APOC2) and GPIHBP1-heparan sulfate interactions Expertise in Hydrogen/Deuterium Exchange Mass Spectrometry and glycopeptide analysis Scientific Leadership: Active in Ph.D. evaluation committees (Swedish Research Council, 2015; multiple international roles) and peer review activities. Funding Involvement: Participates in major projects including Leducq Foundation grants for triglyceride metabolism research, Novo Nordisk Foundation ONE IDP initiatives, and collaborations with GlyProVac ApS. Research Trends: Publications show strong focus on structural dynamics of lipid metabolism proteins (47% of 2023-2025 work), glycopeptide characterization (100% in 2023), and allosteric regulation mechanisms (100% in DNA repair proteins). Collaborations: International partnerships in cardiovascular biology, Parkinson's disease (Michael J. Fox Foundation), and biopharmaceutical safety. Media coverage includes breakthroughs in lipoprotein structure (2014) and Parkinson's research (2014).
Andres Lopez-Contreras serves as an Adjunct Associate Professor in the Department of Cellular and Molecular Medicine at the University of Copenhagen, affiliated with the Molecular Aging Program and Center for Healthy Aging. His research focuses on DNA damage/repair mechanisms, replication stress, and mouse models for cancer and aging. Primary Projects Funded by "Sapere Aude – DFF Starting Grant" on replication stress in aging KVB Project from Danish Cancer Society targeting BRCA1 ubiquitin ligase activity European Research Council (ERC-2015-StG) grant for chromosomal fragile site research Research Network : Collaborates with institutions in Spain (CNIO), USA (NIH), and Denmark (CPR, CEHA). Participants in his group include PhD students Eliene Albers and David Pladevall Morera. Publication Trends : Recent work examines topoisomerase mutations (2025), fragile site instability (2025), ZGRF1 helicase role in fertility (2025), and PICH helicase in lymphoma progression (2024). Labs/Teams Based at Panum Institute, Copenhagen (Blegdamsvej 3) Collaborates with proteomics (Jesper V. Olsen) and mitochondrial genomics (Lene J. Rasmussen) labs
Mathias Spliid Heltberg is an Assistant Professor at the Biocomplexity section of the Niels Bohr Institute, University of Copenhagen. His research focuses on nonlinear dynamics in biological systems, particularly oscillatory mechanisms in cellular processes and medical informatics applications. Current affiliation: Niels Bohr Institute, University of Copenhagen Research areas: Biocomplexity, Systems Biology, Chronobiology His recent publications span topics like p53 dynamics in DNA damage response, signal transmission in excitable media, and medical informatics applications. Collaborations include institutions in Denmark, USA, and China. The research integrates computational modeling with experimental validation in diverse biological contexts. Key contributions include theoretical frameworks for biological oscillations and practical applications in gestational diabetes intervention and surgical outcome prediction. His work on allelic buffering and potassium ion dynamics highlights cross-disciplinary approaches combining physics and biology.
Jakob Møller-Jensen is an Associate Professor and Head of Department at the Department of Biochemistry and Molecular Biology, University of Southern Denmark. With a PhD in his field, he maintains an active research program with 67 publications to date and leads departmental operations. His research focuses on molecular microbiology with emphasis on host-pathogen interactions and pathogenic bacteria. His work primarily investigates Escherichia coli and uropathogenic strains, examining their behavior in urinary tract infections, plasmid dynamics, and bacterial morphology changes during infection processes. His research fingerprint shows strong expertise in Escherichia coli (100%), Uropathogenic Escherichia Coli (95%), Urinary Tract infections (43%), Plasmid biology (43%), RNA mechanisms (31%), Fimbria (31%), Gene Expression (29%), and Caenorhabditis Elegans models (27%). Analysis of his recent publications reveals a consistent focus on bacterial pathogenesis mechanisms, particularly how E. coli adapts to host environments, with special attention to urinary tract infections, bacterial morphology changes, and antibiotic resistance mechanisms. His work bridges fundamental molecular microbiology with clinical implications for infection treatment. Dr. Møller-Jensen has been involved in teaching Chemistry, Biology and Molecular Biology courses from 2009-2019, and has participated in numerous academic activities including conferences, workshops, and seminars. His collaborative network spans multiple countries and research institutions. His current research projects include significant funding from Lundbeckfonden on cellular senescence in cancer (2024-2029), NANOCHEM for ultrahigh resolution chemical characterization (2022-2028), metabolic regulation of mammalian DNA replication (2021-2026), and gut bacteria as biomarkers for colorectal cancer (2023-2025).
David Lopez Martinez is a Researcher in the Department of Cellular and Molecular Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. He works within the Transcription, RNA, and Gene Medicine Program as part of the Svejstrup Group, focusing on molecular mechanisms of transcription and its interface with DNA-related processes. His research spans RNA biology, transcription mechanisms, and DNA repair pathways. Key areas include RNA polymerase II function, transcription termination, DNA damage response pathways, and the Fanconi anemia pathway. His work bridges fundamental molecular processes with potential implications for human health and disease. Dr. Martinez has published significant papers in high-impact journals including Molecular Cell, Journal of Molecular Biology, and Cell Reports. His recent publications (2023-2025) demonstrate expertise in RNA Polymerase II termination mechanisms, PAF1C-mediated kinase activation, and regulation of DNA repair complexes. He maintains active collaborations across multiple institutions, contributing to our understanding of essential cellular processes. His research has garnered attention in the scientific community with multiple citations and downloads of his publications.
Rui Cui is a Guest Researcher at the University of Copenhagen's Faculty of Health and Medical Sciences, Department of Cellular and Molecular Medicine, and Molecular Aging Program, based in Copenhagen, Denmark. Contactable via phone (+4535324771) and email (cuirui@sund.ku.dk), Cui investigates chromosomal instability mechanisms and their impact on human diseases including cancer, neurodegeneration, and infertility. Research centers on genome maintenance pathways, with emphasis on common fragile sites as models for difficult-to-replicate genomic regions and the characterization of ultra-fine anaphase bridges (UFBs)—DNA structures connecting sister chromatids during mitosis. UFBs are coated with proteins like PICH and BLM helicase (mutated in Bloom's syndrome), studied through protein biochemistry, molecular/cell biology, high-resolution imaging, and microfluidics-based single-molecule techniques for in vitro DNA metabolism reconstitution. Recent work trends show a focus on mitotic regulation, exemplified by the 2025 EMBO Journal article on anaphase bridge signaling to the abscission checkpoint, revealing how UFBs influence cell division fidelity and disease pathogenesis. This aligns with broader efforts to link defective genome maintenance to cancer predisposition. Cui operates within the Hickson Group, a research team dedicated to understanding disease-causing mutations in genome maintenance genes. Collaborative efforts span country-level networks in molecular aging research, leveraging advanced biophysical tools to dissect DNA metabolism pathways.
